Discover 2,367 paid clinical trials in Plainfield, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Plainfield offers many clinical trial opportunities with focuses on various conditions, including ADHD, prurigo nodularis, autoimmune diseases like lupus, and cardiovascular conditions. The city's leading institutions are actively recruiting both healthy volunteers interested in paid research options, as well as those with specific health conditions for studies that could lead to groundbreaking discoveries and improved treatments.
Filter
2
Filter results
Results: 2,367
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
for
Colorectal Neoplasms
Location: Arlington Heights IL, Peoria IL, Milwaukee WI,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06750094
Phase3, Recruiting
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
for
Limited Stage Small Cell Lung Cancer
Location: Arlington Heights IL, Peoria IL, Indianapolis IN,
Sponsor: SCRI Development Innovations, LLC
Sex: All
Age: 18+
Code: NCT06773910
Phase2, Recruiting
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
for
Colorectal Neoplasms
Location: Arlington Heights IL, Peoria IL, Madison WI,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06662786
Phase3, Recruiting
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
for
Triple-Negative Breast Cancer
Location: Arlington Heights IL, Dyer IN, Skokie IL, Madison WI,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06393374
Phase3, Recruiting
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
for
Viral Lung Infection and Acute Respiratory Failure
Location: Evanston IL, St Louis MO, Detroit MI, Royal Oak MI,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT05624450
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Milrinone for Prevention of Post-ligation Cardiac Syndrome Trial
for
Post-ligation Cardiac Syndrome
Location: Chicago IL, Iowa City IA, Cincinnati OH, Cleveland OH,
Sponsor: NICHD Neonatal Research Network
Sex: All
Age: 0
Code: NCT06679855
Phase3, Recruiting
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
for
Metastatic Prostate Cancer
Location: Arlington Heights IL, Lake Barrington IL,
Sponsor: ORIC Pharmaceuticals
Sex: Male
Age: 18+
Code: NCT05413421
Phase1, Recruiting
Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations
for
Solid Tumours
Location: Arlington Heights IL, Indianapolis IN, Maumee OH,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT06581432
Phase2, Recruiting
Breast Cancer Liquid Biopsy Trial
for
Breast Cancer, Cancer
Location: Arlington Heights IL, New York NY, Bronx NY, Ocala FL,
Sponsor: Anthony Magliocco
Sex: All
Age: 18+
Code: NCT04962529
Recruiting
Preventing Tipping Points in High Comorbidity Patients: A Lifeline From Health Coaches
for
Comorbidity, Self-Management
Location: Chicago IL, Brooklyn NY, New York NY
Sponsor: Clinical Directors Network
Sex: All
Age: 18+
Code: NCT04176510
Recruiting
A Study to Determine the Efficacy and Safety of Tividenofusp Alfa (DNL310) vs Idursulfase in Pediatric and Young Adult Participants With Neuronopathic (nMPS II) or Non-Neuronopathic Mucopolysaccharidosis Type II (nnMPS II)
for
Mucopolysaccharidosis II
Location: Chicago IL, Cincinnati OH, Toronto, Chapel Hill NC,
Sponsor: Denali Therapeutics Inc.
Sex: All
Age: 2 - 25
Code: NCT05371613
Phase2, Phase3, Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Location: Chicago IL, Cleveland OH, Nashville TN, Denver CO,
Sponsor: InSilico Medicine Hong Kong Limited
Sex: All
Age: 18+
Code: NCT06566079
Phase1, Recruiting
Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation